Bring Life-Saving Lung Cancer Screening to Your Community
USA Mobile Medical is one of the country's leading manufacturers of mobile lung cancer screening CT coaches — delivering purpose-built, turnkey programs that help hospitals, cancer centers, and health systems expand access to high-risk populations.
Lung Cancer Is the Most Preventable Cancer Death — Yet Most Go Unscreened
Lung cancer accounts for more deaths than breast, prostate, and pancreatic cancers combined. Early detection through low-dose CT (LDCT) screening is proven to save lives — yet access, capacity, and awareness gaps continue to limit program growth across the country.
Only 26% of lung cancer cases are diagnosed at an early stage, when treatment options are most effective and costs are dramatically lower.
The Communities That Need It Most Are the Hardest to Reach
Rural and underserved communities face the highest lung cancer burden — and the fewest resources to address it. An estimated 17–20% of the U.S. population lives in rural areas, yet they have access to only 3% of the country's practicing medical oncologists. Over 70% of U.S. counties have no access to medical oncologists at all.
Rural & Underserved Communities
Limited specialist access, older populations, and socioeconomic barriers lead to later diagnoses and worse outcomes. Mobile screening brings the solution directly to patients.
Firefighters & First Responders
According to NIOSH, firefighters face a 9% increase in cancer diagnosis and 14% higher cancer-related deaths. Carcinogen exposure on the job puts them at significant risk.
EMS / EMT Professionals
EMS workers often respond to the same toxic exposure events as firefighters, frequently with less protective equipment. Cancer is among the leading occupational health threats they face.
Purpose-Built Lung CT Coaches
Custom 40' and 45' drivable coaches and 48' trailer platforms designed specifically for low-dose CT lung cancer screening — with full clinical-grade interiors built to your specifications.
Turnkey Program Support
Deployment planning, site assessments, workflow design, transport logistics, ongoing maintenance, and technical support — everything you need to launch and sustain a high-performing program.
Philips Authorized CT Partner
USAMM holds a partnership agreement with Philips for new CT coach builds, giving you access to the Philips Incisive CT 5100 and CT 5300 — optimized for low-dose lung cancer screening protocols.
Scalable Program Models
Many partners begin with lung cancer screening and expand into additional services over time. Rental, lease, or purchase options — aligned with your goals.
University of Arkansas for Medical Sciences (UAMS)
USA Mobile Medical delivered three custom 45' Drivable Lung Cancer Screening CT Coaches to UAMS's Winthrop P. Rockefeller Cancer Institute — in partnership with Philips — to support UAMS's statewide lung cancer screening and early detection programs.
These purpose-built coaches extend UAMS's reach beyond traditional hospital settings, providing mobile access to high-risk populations across both urban and rural communities throughout Arkansas. Each coach features advanced low-dose CT scanning technology, a dedicated patient intake space, and custom exterior branding aligned with UAMS's cancer prevention mission.
This multi-unit deployment supports UAMS's long-term strategy to expand screening capacity, improve early detection rates, and deliver consistent, high-quality care statewide.
Launching a Mobile Lung Cancer Screening Program
Bringing lung cancer screening to underserved communities requires strategic planning, the right technology, and strong partnerships. Here's how USAMM helps you get there.
Assess Community Needs & Define Goals
Conduct a community health assessment to identify high-risk populations, map geographic coverage gaps, and set measurable program goals such as screening volumes and early detection targets.
Secure Funding & Financial Support
Explore federal and state grants, nonprofit funding (LCRF, LUNGevity, ALA/ACS), hospital budget allocations, and USAMM's flexible lease and financing options to minimize upfront capital.
Select the Right Mobile Platform
Choose your platform (drivable coach or trailer), OEM CT system, and configuration based on patient volume, deployment frequency, site access, and program scalability goals.
Build Your Screening Team & Train Staff
Recruit technologists, nurses, and program coordinators. Establish workflows for scheduling, image interpretation, and follow-up care. USAMM supports onboarding and go-live readiness.
Develop Community Outreach & Awareness
Partner with local clinics, employers, fire departments, and public health organizations. Use social media, direct outreach, and health fairs to inform and engage eligible patients.
Launch, Track & Scale Your Program
Begin with a pilot phase to refine logistics. Use data and outcomes tracking to measure impact. Scale deployment days, locations, or units as screening demand grows.
Ready to get started? Our team has guided multiple health systems through every step of this process.
Schedule a Program ConsultationFunding Pathways for Your Program
Launching a lung cancer screening program requires investment — but a range of grants, financing models, and partnerships can make it more accessible than you might think.
Lung Cancer Research Foundation (LCRF)
Supports prevention and early detection initiatives focused on improving lung cancer screening uptake and outcomes.
LUNGevity Foundation
Funds early detection and health equity research programs that address disparities in lung cancer screening access.
The Mark Foundation
Provides significant funding for innovative early cancer detection approaches, including mobile lung screening.
American Lung Association & American Cancer Society
Offer research and programmatic grants supporting lung health, screening initiatives, and early diagnosis.
Federal & State Initiatives
Emerging federal legislation and state health grants increasingly prioritize mobile cancer screening — particularly for rural and underserved communities.
Mobile screening programs eliminate the need for permanent construction or long-term real estate commitments. Hospitals can deploy screening capacity without building new imaging suites — making mobile a lower-risk, more flexible alternative to fixed-site expansion.
LDCT Screening Eligibility & At-Risk Populations
Understanding who qualifies for low-dose CT screening — and who is most at risk — is the foundation of an effective mobile lung cancer screening program.
USPSTF Screening Guidelines (2021)
- Age 50–80 years — annual low-dose CT screening recommended
- 20 pack-year smoking history — (e.g., 1 pack/day for 20 years, or 2 packs/day for 10 years)
- Currently smoke or have quit within the past 15 years
- Screening should be discontinued if the person has not smoked in 15+ years or develops a health problem that limits life expectancy or ability to have curative lung surgery
Source: U.S. Preventive Services Task Force (USPSTF), 2021 Recommendation. Medicare and most private insurers cover annual LDCT screening for eligible individuals at no cost-sharing.
High-Priority At-Risk Populations
Rural & Underserved Communities
17–20% of the U.S. population lives in rural areas with access to only 3% of practicing oncologists. Over 70% of counties have no oncologists at all.
Firefighters
Regular carcinogen exposure leads to a 9% increase in cancer diagnosis and 14% higher cancer-related deaths (NIOSH).
EMS / EMT Professionals
Often younger than traditional screening age guidelines, but face similar carcinogen exposure risks — particularly without adequate PPE at toxic events.
Occupational Exposure Groups
Workers in manufacturing, mining, construction, and agriculture with known asbestos, radon, or chemical carcinogen exposure face elevated lifetime lung cancer risk.
Ready to Bring Lung Cancer Screening to Your Community?
Whether you're launching a new program, expanding an existing initiative, or exploring what's possible for your patient population — USAMM's engineering team and program specialists are ready to help you build a solution that delivers real impact.
